In a deviously inventive sting operation, Congress appears to be taking aim at the private review boards that the Food and Drug Administration (FDA) trusts to protect patients who enroll in thousands of clinical trials of drugs, biologics and medical devices.
http://bulletin.aarp.org/yourhealth/policy/articles/safety_of_drug_trials_tested.html
Comments on this entry are closed.